Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs

Regorafenib resistance is a key limiting factor in the treatment of advanced hepatocellular carcinoma (HCC). Increasing evidence has demonstrated that Berberine (BBR) can synergistically enhance the therapeutic effect of various chemotherapeutic agents. However, the contribution of BBR on regorafeni...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Wang, Kunyuan, Yu, Ganxiang, Lin, Jiaen, Wang, Zhilei, Lu, Qianting, Gu, Chengxin, Yang, Tao, Liu, Shiming, Yang, Hui
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248669/
https://ncbi.nlm.nih.gov/pubmed/34220494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.632201
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi